Suppr超能文献

美国城市血液透析人群中液体超负荷的流行情况:一项横断面研究。

Prevalence of fluid overload in an urban US hemodialysis population: A cross-sectional study.

机构信息

Fresenius Medical Care Deutschland GmbH, Bad Homburg, Hessen, Germany.

Renal Research Institute, New York, New York, USA.

出版信息

Hemodial Int. 2022 Apr;26(2):264-273. doi: 10.1111/hdi.12986. Epub 2021 Dec 12.

Abstract

INTRODUCTION

Inadequate fluid status remains a key driver of cardiovascular morbidity and mortality in chronic hemodialysis (HD) patients. Quantification of fluid overload (FO) using bioimpedance spectroscopy (BIS) has become standard in many countries. To date, no BIS device has been approved in the United States for fluid status assessment in kidney patients. Therefore, no previous quantification of fluid status in US kidney patients using BIS has been reported. Our aim was to conduct a cross-sectional BIS-based assessment of fluid status in an urban US HD population.

METHODS

We determined fluid status in chronic HD patients using whole body BIS (Body Composition Monitor, BCM). The BCM reports FO in liters; negative FO denotes fluid depletion. Measurements were performed before dialysis. Post-HD FO was estimated by subtracting the intradialytic weight loss from the pre-HD FO.

FINDINGS

We studied 170 urban HD patients (age 61 ± 14 years, 60% male). Pre- and post-HD FO (mean ± SD), were 2.2 ± 2.4 and -0.2 ± 2.7 L, respectively. Pre-HD, 43% of patients were fluid overloaded, 53% normally hydrated, and 4% fluid depleted. Post-HD, 12% were fluid overloaded, 55% normohydrated and 32% fluid depleted. Only 48% of fluid overloaded patients were hypertensive, while 38% were normotensive and 14% hypotensive. Fluid status did not differ significantly between African Americans (N = 90) and Caucasians (N = 61).

DISCUSSION

While about half of the patients had normal fluid status pre-HD, a considerable proportion of patients was either fluid overloaded or depleted, indicating the need for tools to objectively quantify fluid status.

摘要

简介

在慢性血液透析(HD)患者中,液体状态不足仍然是心血管发病率和死亡率的关键驱动因素。使用生物阻抗谱(BIS)量化液体超负荷(FO)已在许多国家成为标准。迄今为止,还没有任何 BIS 设备获得美国批准用于评估肾病患者的液体状态。因此,以前没有报告过使用 BIS 在美国肾病患者中评估液体状态的情况。我们的目的是使用基于 BIS 的横断面研究来评估美国城市 HD 人群的液体状态。

方法

我们使用全身 BIS(身体成分监测仪,BCM)来确定慢性 HD 患者的液体状态。BCM 以升报告 FO;负 FO 表示液体耗竭。测量是在透析前进行的。透析后 FO 通过从透析前 FO 中减去透析期间的体重减轻量来估计。

结果

我们研究了 170 名城市 HD 患者(年龄 61±14 岁,60%为男性)。透析前和透析后 FO(平均值±标准差)分别为 2.2±2.4 和-0.2±2.7 L。透析前,43%的患者存在液体超负荷,53%的患者处于正常水化状态,4%的患者存在液体耗竭。透析后,12%的患者存在液体超负荷,55%的患者处于正常水化状态,32%的患者存在液体耗竭。只有 48%的液体超负荷患者患有高血压,而 38%的患者血压正常,14%的患者血压偏低。非洲裔美国人(N=90)和白种人(N=61)之间的液体状态没有显著差异。

讨论

虽然约有一半的患者在透析前液体状态正常,但相当一部分患者存在液体超负荷或耗竭,这表明需要使用工具来客观地量化液体状态。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验